ArticleVeterinary research2025
Mesomycoplasma hyopneumoniae lipoprotein Mhp390 serves as a plasminogen receptor mediating extracellular matrix degradation and respiratory epithelial cells injury.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rethinking Mycoplasma hyopneumoniae adhesion: a glycocalyx-mediated infectious niche model in porcine respiratory infection.Veterinary research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The destruction of the respiratory barrier caused by Mesomycoplasma (Mycoplasma) hyopneumoniae plays a pivotal role in facilitating secondary infections by other respiratory pathogens. However, the pathogenesis of M. hyopneumoniae breaching the respiratory barrier to establish infection remains largely elusive. In this study, the role of Mhp390 encoded by M. hyopneumoniae in invasion of the respiratory tract barrier, including extracellular matrix and tracheal epithelial cells, were investigated through the Transwell assay. Our finding indicated that M. hyopneumoniae may exploit the host fibrinolytic system via Mhp390 to accumulate activated plasmin outside its membrane, thereby breaching the respiratory tract barrier and facilitating the progression of infection. Furthermore, the key functional domains within Mhp390 involved in its interaction with host plasminogen were determined by using truncated mutation techniques. Collectively, these findings will enhance our understanding of the mechanism underlying respiratory barrier invasion by M. hyopneumoniae thereby providing new theoretical basis for the development of novel vaccines and effective control strategies against secondary infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.